Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Pro-glucagon' and Ligand = 'BDBM100823'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Pro-glucagon (Homo sapiens (Human))	BDBM100823 (US8507533, 130 | US8507533, 369) Show SMILES CCCC(Oc1cc(C)c(c(C)c1)-n1cc(Cl)cn1)c1ccc(cc1)C(=O)NCCC(O)=O Show InChI InChI=1S/C25H28ClN3O4/c1-4-5-22(18-6-8-19(9-7-18)25(32)27-11-10-23(30)31)33-21-12-16(2)24(17(3)13-21)29-15-20(26)14-28-29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,27,32)(H,30,31)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	93.2	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.				US Patent US8507533 (2013) BindingDB Entry DOI: 10.7270/Q23R0RGH
					More data for this Ligand-Target Pair
Pro-glucagon (Homo sapiens (Human))	BDBM100823 (US8507533, 130 | US8507533, 369) Show SMILES CCCC(Oc1cc(C)c(c(C)c1)-n1cc(Cl)cn1)c1ccc(cc1)C(=O)NCCC(O)=O Show InChI InChI=1S/C25H28ClN3O4/c1-4-5-22(18-6-8-19(9-7-18)25(32)27-11-10-23(30)31)33-21-12-16(2)24(17(3)13-21)29-15-20(26)14-28-29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,27,32)(H,30,31)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	116	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.				US Patent US8507533 (2013) BindingDB Entry DOI: 10.7270/Q23R0RGH
					More data for this Ligand-Target Pair